Cowen & Co downgrades Savient Pharmaceuticals (Nasdaq: SVNT) to Underperform

Cowen analyst says, "We are downgrading SVNT from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE